Aptinyx Inc. 3 SEC Filings

Filed On	Filing
22 Oct 2021	Form 3: O'Neill Gilmore Neil, Director No securities owned
12 May 2021	Form 3: Miller Joan W., Director No securities owned
16 Jan 2020	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 4 others Holds 5,558,425 shares of Common Stock
04 Sep 2019	Form 3: Sherman Rachel E., Director No securities owned
07 May 2019	Form 3: Gosebruch Henry O, Director No securities owned
20 Jun 2018	Form 3: Koppel Adam, Director
20 Jun 2018	Form 3: New Leaf Venture Management III, L.l.c., 10% owner and 4 others
20 Jun 2018	Form 3: Frazier Life Sciences VIII, L.p., 10% owner and 3 others
20 Jun 2018	Form 3: Hombach Robert J., Director
20 Jun 2018	Form 3: Longitude Capital Partners II, Llc, 10% owner and 2 others
20 Jun 2018	Form 3: Topper James N, Director
20 Jun 2018	Form 3: Ratcliffe Liam, Director
20 Jun 2018	Form 3: Adams Street Partners Llc, 10% owner Holds 249,791 shares of Common Stock
20 Jun 2018	Form 3: Gould Terry P, Director Holds 249,791 shares of Common Stock
20 Jun 2018	Form 3: Enright Patrick G, Director
20 Jun 2018	Form 3: Gantz Wilbur H, Director Holds 108,622 shares of Common Stock
20 Jun 2018	Form 3: Houck David, Chief Development Officer Holds 33,596 shares of Common Stock
20 Jun 2018	Form 3: Moskal Joseph R., Chief Scientific Officer Holds 350,599 shares of Common Stock
20 Jun 2018	Form 3: Madsen Torsten M., Chief Medical Officer Holds 223,761 shares of Common Stock
20 Jun 2018	Form 3: Kidd Andrew, Chief Commercial Officer

Comments